Prestige Consumer Healthcare EBIT Margin 2010-2024 | PBH
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Prestige Consumer Healthcare (PBH) over the last 10 years. The current EBIT profit margin for Prestige Consumer Healthcare as of December 31, 2024 is .
| Prestige Consumer Healthcare EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2024-12-31 | $1.12B | $0.33B | 29.52% |
| 2024-09-30 | $1.11B | $0.33B | 29.25% |
| 2024-06-30 | $1.11B | $0.33B | 29.56% |
| 2024-03-31 | $1.13B | $0.34B | 30.40% |
| 2023-12-31 | $1.13B | $-0.02B | -1.85% |
| 2023-09-30 | $1.13B | $-0.02B | -1.86% |
| 2023-06-30 | $1.13B | $-0.03B | -2.21% |
| 2023-03-31 | $1.13B | $-0.02B | -2.04% |
| 2022-12-31 | $1.11B | $0.34B | 30.21% |
| 2022-09-30 | $1.11B | $0.33B | 29.90% |
| 2022-06-30 | $1.09B | $0.33B | 29.80% |
| 2022-03-31 | $1.09B | $0.33B | 30.39% |
| 2021-12-31 | $1.06B | $0.32B | 30.65% |
| 2021-09-30 | $1.02B | $0.31B | 30.72% |
| 2021-06-30 | $0.98B | $0.31B | 31.33% |
| 2021-03-31 | $0.94B | $0.30B | 31.50% |
| 2020-12-31 | $0.96B | $0.30B | 31.38% |
| 2020-09-30 | $0.96B | $0.30B | 31.60% |
| 2020-06-30 | $0.96B | $0.30B | 31.15% |
| 2020-03-31 | $0.96B | $0.29B | 30.11% |
| 2019-12-31 | $0.95B | $0.06B | 6.61% |
| 2019-09-30 | $0.95B | $0.07B | 6.83% |
| 2019-06-30 | $0.95B | $0.07B | 7.03% |
| 2019-03-31 | $0.98B | $0.07B | 6.97% |
| 2018-12-31 | $0.99B | $0.20B | 20.00% |
| 2018-09-30 | $1.02B | $0.20B | 20.00% |
| 2018-06-30 | $1.04B | $0.21B | 20.12% |
| 2018-03-31 | $1.04B | $0.22B | 20.73% |
| 2017-12-31 | $1.03B | $0.29B | 28.43% |
| 2017-09-30 | $0.97B | $0.28B | 28.47% |
| 2017-06-30 | $0.93B | $0.27B | 29.25% |
| 2017-03-31 | $0.88B | $0.21B | 23.22% |
| 2016-12-31 | $0.85B | $0.22B | 25.53% |
| 2016-09-30 | $0.83B | $0.21B | 25.33% |
| 2016-06-30 | $0.82B | $0.21B | 25.49% |
| 2016-03-31 | $0.81B | $0.26B | 32.38% |
| 2015-12-31 | $0.79B | $0.26B | 32.61% |
| 2015-09-30 | $0.79B | $0.25B | 31.93% |
| 2015-06-30 | $0.76B | $0.23B | 29.96% |
| 2015-03-31 | $0.72B | $0.21B | 29.09% |
| 2014-12-31 | $0.67B | $0.19B | 28.74% |
| 2014-09-30 | $0.62B | $0.18B | 28.46% |
| 2014-06-30 | $0.60B | $0.18B | 30.28% |
| 2014-03-31 | $0.60B | $0.19B | 31.44% |
| 2013-12-31 | $0.61B | $0.19B | 31.85% |
| 2013-09-30 | $0.62B | $0.20B | 32.21% |
| 2013-06-30 | $0.62B | $0.20B | 31.98% |
| 2013-03-31 | $0.62B | $0.19B | 30.97% |
| 2012-12-31 | $0.60B | $0.17B | 27.36% |
| 2012-09-30 | $0.55B | $0.14B | 25.87% |
| 2012-06-30 | $0.49B | $0.12B | 24.34% |
| 2012-03-31 | $0.44B | $0.10B | 23.36% |
| 2011-12-31 | $0.40B | $0.10B | 24.57% |
| 2011-09-30 | $0.39B | $0.09B | 22.68% |
| 2011-06-30 | $0.36B | $0.08B | 23.06% |
| 2011-03-31 | $0.34B | $0.08B | 22.92% |
| 2010-12-31 | $0.31B | $0.08B | 24.43% |
| 2010-09-30 | $0.29B | $0.09B | 29.31% |
| 2010-06-30 | $0.29B | $0.08B | 27.65% |
| 2010-03-31 | $0.29B | $0.08B | 26.96% |
| 2009-12-31 | $0.28B | $-0.17B | -60.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.259B | $1.125B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
| Boston Scientific (BSX) | United States | $149.209B | 40.19 |
| Stryker (SYK) | United States | $142.084B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
| Medtronic (MDT) | Ireland | $115.249B | 16.83 |
| Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
| Agilent Technologies (A) | United States | $33.351B | 22.03 |
| ResMed (RMD) | United States | $32.876B | 25.32 |
| Terumo (TRUMY) | Japan | $27.805B | 39.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
| Insulet (PODD) | United States | $18.442B | 78.86 |
| Baxter (BAX) | United States | $17.557B | 12.63 |
| Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Demant (WILYY) | Denmark | $8.048B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
| Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
| Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.405B | 29.11 |
| Haemonetics (HAE) | United States | $3.193B | 15.02 |
| Envista Holdings (NVST) | United States | $2.972B | 23.64 |
| QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
| GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
| LeMaitre Vascular (LMAT) | United States | $1.893B | 43.25 |
| Neogen (NEOG) | United States | $1.881B | 21.67 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
| Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
| InMode (INMD) | Israel | $1.234B | 10.31 |
| Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
| BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
| Evolus (EOLS) | United States | $0.765B | 0.00 |
| Owens & Minor (OMI) | United States | $0.698B | 5.94 |
| CeriBell (CBLL) | United States | $0.689B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
| Valneva SE (VALN) | France | $0.545B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.436B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
| SNDL (SNDL) | Canada | $0.371B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| ZimVie (ZIMV) | United States | $0.301B | 18.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Quanterix (QTRX) | United States | $0.252B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
| Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Brainsway (BWAY) | Israel | $0.178B | 55.71 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| High Tide (HITI) | Canada | $0.153B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.116B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 12.18 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 24.44 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| Exagen (XGN) | United States | $0.064B | 0.00 |
| InterCure (INCR) | Israel | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 12.66 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
| Safety Shot (SHOT) | United States | $0.027B | 0.00 |
| INLIF (INLF) | $0.021B | 0.00 | |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |